Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression

Author： Darbinyan V.   Aslanyan G.   Amroyan E.   Gabrielyan E.   Malmström C.   Panossian A.  

Publisher： Informa Healthcare

ISSN： 0803-9488

Source： Nordic Journal of Psychiatry, Vol.61, Iss.5, 2007-01, pp. : 343-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD

By  

Current Alzheimer Research, Vol. 2, Iss. 3, 2005-07 ,pp. : 343-353

Bentham Science Publishers

Access to resources Recommend Favorite

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 83-89

Bentham Science Publishers

Access to resources Recommend Favorite

The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 2, 2014-02 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite

An Open Trial of Olanzapine in the Treatment of Patients with Psychotic Depression

By Nelson E.B.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 147-151

Springer Publishing Company

Access to resources Recommend Favorite

Use of Valdoxan (Agomelatin) in the Combined Treatment of Moderate and Severe Nonpsychotic Depression

By Medvedev V.  

Neuroscience and Behavioral Physiology, Vol. 43, Iss. 7, 2013-09 ,pp. : 878-882

Springer Publishing Company

Access to resources Recommend Favorite